Sodium Cridanimod
VX-EC-2-02
Phase 2 small_molecule terminated
Quick answer
Sodium Cridanimod for Endometrial Cancer is a Phase 2 program (small_molecule) at Xenetic Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xenetic Biosciences
- Indication
- Endometrial Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated